Literature DB >> 7670466

Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease.

K Horinouchi1, S Erlich, D P Perl, K Ferlinz, C L Bisgaier, K Sandhoff, R J Desnick, C L Stewart, E H Schuchman.   

Abstract

Types A and B Niemann-Pick disease (NPD) result from the deficient activity of acid sphingomyelinase (ASM). An animal model of NPD has been created by gene targeting. In affected animals, the disease followed a severe, neurodegenerative course and death occurred by eight months of age. Analysis of these animals showed their tissues had no detectable ASM activity, the blood cholesterol levels and sphingomyelin in the liver and brain were elevated, and atrophy of the cerebellum and marked deficiency of Purkinje cells was evident. Microscopic analysis revealed 'NPD cells' in reticuloendothelial organs and characteristic NPD lesions in the brain. Thus, the ASM deficient mice should be of great value for studying the pathogenesis and treatment of NPD, and for investigations into the role of ASM in signal transduction and apoptosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7670466     DOI: 10.1038/ng0795-288

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  155 in total

Review 1.  The therapeutic potential of modulating the ceramide/sphingomyelin pathway.

Authors:  Richard Kolesnick
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

2.  Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipid metabolism.

Authors:  Flavia Antonucci; Elena Turola; Loredana Riganti; Matteo Caleo; Martina Gabrielli; Cristiana Perrotta; Luisa Novellino; Emilio Clementi; Paola Giussani; Paola Viani; Michela Matteoli; Claudia Verderio
Journal:  EMBO J       Date:  2012-01-13       Impact factor: 11.598

3.  Systematic Genetic Analysis of the SMPD1 Gene in Chinese Patients with Parkinson's Disease.

Authors:  Sheng Deng; Xiong Deng; Zhi Song; Xiaofei Xiu; Yi Guo; Jingjing Xiao; Hao Deng
Journal:  Mol Neurobiol       Date:  2015-09-16       Impact factor: 5.590

4.  Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis.

Authors:  I Herr; D Wilhelm; T Böhler; P Angel; K M Debatin
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

5.  Acid sphingomyelinase deficiency increases susceptibility to fatal alphavirus encephalomyelitis.

Authors:  Ching G Ng; Diane E Griffin
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

Review 6.  Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.

Authors:  Catherine Pavoine; Françoise Pecker
Journal:  Cardiovasc Res       Date:  2009-01-28       Impact factor: 10.787

7.  Acid Sphingomyelinase Deficiency Prevents Diet-induced Hepatic Triacylglycerol Accumulation and Hyperglycemia in Mice.

Authors:  Gergana M Deevska; Krassimira A Rozenova; Natalia V Giltiay; Melissa A Chambers; James White; Boris B Boyanovsky; Jia Wei; Alan Daugherty; Eric J Smart; Michael B Reid; Alfred H Merrill; Mariana Nikolova-Karakashian
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

Review 8.  Glycosphingolipid degradation and animal models of GM2-gangliosidoses.

Authors:  T Kolter; K Sandhoff
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

Review 9.  Animal models of lysosomal disease: an overview.

Authors:  K Suzuki; J E Månsson
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

10.  Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice.

Authors:  Carmen García-Ruiz; Anna Colell; Montserrat Marí; Albert Morales; María Calvo; Carlos Enrich; José C Fernández-Checa
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.